Medicines in Kazakhstan rose by 7% in 2018 Q1, Energyprom.kz reports. According to 2018 first quarter results, prices for pharmaceutical products rose 2% compared to the previous quarter and by 6.6% on-year. The most noticeable annual price rise was recorded in the hormonal drugs segment – by
The State Medicines Control Agency on the ground of market monitoring data has compiled the list of medicinal products authorized in the Republic of Lithuania which more than for three years had not been supplied to the Lithuanian market. Following Part 7 Article 14 of the Law on Pharmacy in the
In February 2018, the Bulgarian Drug Agency (BDA) announced new requirements for fee payments which are important for all applicants, marketing authorisation holders and their representatives. When requesting an administrative service for marketing authorization/registration, variations, renewals